Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Asian elephant survives Ebola-like virus
Tarli with Woburn’s head elephant keeper Darren Fellowes.

Vets treat three-year-old Tarli for Endotheliotropic herpes virus

An Asian elephant has beaten the odds to survive an Ebola-like virus which is fatal in 80 per cent of recorded cases.

Elephant endotheliotropic herpesvirus (EEHV) is a highly fatal disease that weakens the circulatory system in young elephants leading to rapid deterioration.

In November 2017, keepers at Woburn Safari Park carried out a routine blood test on three-year-old Tarli, which revealed that she had EEHV infection. Although she did not have any clinical signs, vets began treatment immediately to give her the best chance of survival.

Treatment for EEHV is mostly supportive, focussing on maintaining bodily function while the immune system fights the disease. A two-week course of antiviral and transfusions was combined with 24-hour supervision from keepers who had cared for Tarli since she was born.

“EEHV is an awful virus, targeting the youngest members of the herd. As keepers we spend more time with our animals than our families and all of us are so relieved at how positively Tarli has responded to treatment,” said Darren Fellowes, Woburn’s head elephant keeper.

The keepers focussed on keeping Tarli calm so that she could remain with the rest of the herd and keep to her usual routine. In a press release, Woburn Safari Park said that the use of intravenous ganciclovir and plasma has had a successful outcome and ‘opens the door to offering alternative treatment protocols’.

It has now been six weeks since Tarli received the all-clear. However, there is still a chance of relapse. The team are cautiously celebrating her recovery whilst they continue to monitor her closely.

Woburn Safari Park raises money for International Elephant Foundation which invests in elephant conservation and research, including for an EEHV vaccine.

“EEHV is the most serious medical threat to the survival of Asian elephant calves. Every case builds on the experience of others, and the body of research around earlier cases allowed us to create an effective treatment programme for Tarli, and ultimately saved her life,” explained specialist vet Nathalie Wissink-Argilaga who led Tarli’s treatment.

“Details of Tarli’s recovery are being shared with the international veterinary community and we hope to share lessons on the value of swift treatment, stress-reduction, continuous monitoring of viral loads and blood parameters and intravenous administration of antivirals and plasma.” 

Image (C) Woburn Safari Park

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.